ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 86 filers reported holding ALLOVIR INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $93 | -7.0% | 43,086 | +47.8% | 0.00% | – |
| Q2 2023 | $100 | -2.9% | 29,153 | +11.6% | 0.00% | – |
| Q1 2023 | $103 | -48.8% | 26,120 | -33.2% | 0.00% | – |
| Q4 2022 | $201 | -99.9% | 39,115 | -20.8% | 0.00% | – |
| Q3 2022 | $390,000 | +98.0% | 49,369 | -2.5% | 0.00% | – |
| Q2 2022 | $197,000 | +6.5% | 50,611 | +84.2% | 0.00% | – |
| Q1 2022 | $185,000 | -30.5% | 27,475 | +33.5% | 0.00% | – |
| Q4 2021 | $266,000 | – | 20,575 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 5,577,167 | $44,004,000 | 1.88% |
| GMT CAPITAL CORP | 2,758,846 | $21,767,000 | 1.35% |
| Regency Capital Management Inc.\DE | 75,010 | $592,000 | 0.73% |
| Redmile Group, LLC | 1,907,969 | $15,054,000 | 0.58% |
| Samsara BioCapital, LLC | 82,336 | $650,000 | 0.15% |
| Alkeon Capital Management | 4,923,104 | $38,843,000 | 0.13% |
| Woodline Partners LP | 1,087,093 | $8,577,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 77,625 | $612,000 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 44,987 | $355,000 | 0.07% |
| AMERICAN INTERNATIONAL GROUP, INC. | 1,143,634 | $9,023,000 | 0.07% |